Status:

WITHDRAWN

Novel Testing Procedures

Lead Sponsor:

Medical College of Wisconsin

Collaborating Sponsors:

Baxter Healthcare Corporation

Conditions:

Immunodeficiencies

Eligibility:

All Genders

1-80 years

Brief Summary

The purpose of this study is to evaluate a novel screening test to detect patients with primary immunodeficiencies(PIDs). The investigators plan to use information gained from this study in order to a...

Detailed Description

After consent is obtained, blood will be obtained. The total amount of blood to drawn in one day will not exceed 1.5 mL (1/3 tsp) per pound of body weight. All samples will be collected at the same ti...

Eligibility Criteria

Inclusion

  • Any subject having testing done to evaluate the immune system is eligible for this study.

Exclusion

  • Inability or unwillingness on the part of the parents or individual to provide clinical or family history, or refusal to allow blood sampling.

Key Trial Info

Start Date :

April 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2017

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01793506

Start Date

April 1 2016

End Date

June 1 2017

Last Update

January 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asthma, Allergy & Immunology Clinics Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Novel Testing Procedures | DecenTrialz